http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110628802-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-74
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-16
filingDate 2019-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110628802-B
titleOfInvention Sorangium cellulosum for high-yield epothilone D and construction method and application thereof
abstract The invention discloses sorangium cellulosum for high-yield epothilone D and a construction method and application thereof. The construction of the recombinant sorangium cellulosum So ce M4 strain with the epoK gene knocked out by utilizing the TALEN technology is disclosed for the first time, and experiments prove that the epoK gene in the sorangium cellulosum So ce M4 strain knocked out by utilizing the TALEN technology can obviously improve the yield of epothilone D and simultaneously reduce the yield of epothilone B, thereby realizing the oriented biosynthesis of the epothilone in sorangium cellulosum. The invention discloses the method for improving the yield of epothilone production by sorangium cellulosum by using the TALEN technology for the first time, and the application of the TALEN technology to the improvement of the yield of epothilone D production by sorangium cellulosum can promote the biosynthesis of epothilone while promoting the development of the genetic engineering modification technology of sorangium cellulosum, expand the application of epothilone D in the aspect of tumor resistance, and have very important significance for the development of biological medicines in China.
priorityDate 2019-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126456220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23305354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490002

Total number of triples: 29.